Decline of Nonrecommended HIV Care in Medicare
|
A recent study shows a substantial decline in the use of
nonrecommended antiviral prescriptions among Medicare beneficiaries with HIV. |
Nigeria : New HIV Drug May Exclude Vulnerable Populations
The recent approval of Yeztugo, a twice-yearly injectable medication for HIV prevention, has sparked global debate as health experts warn that its ... View article...